Company registration number 02913864 (England and Wales)
SURESITE HEALTH & SAFETY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
SURESITE HEALTH & SAFETY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
SURESITE HEALTH & SAFETY LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
4,082
2,055
Current assets
Debtors
4
726,077
500,828
Cash at bank and in hand
88,268
117,742
814,345
618,570
Creditors: amounts falling due within one year
5
(190,113)
(133,146)
Net current assets
624,232
485,424
Total assets less current liabilities
628,314
487,479
Provisions for liabilities
(629)
(36)
Net assets
627,685
487,443
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
627,585
487,343
Total equity
627,685
487,443

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

SURESITE HEALTH & SAFETY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2024
31 March 2024
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 4 November 2024 and are signed on its behalf by:
Mr J G Oldham
Mr N  Healy
Director
Director
Company Registration No. 02913864
SURESITE HEALTH & SAFETY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -
1
Accounting policies
Company information

Suresite Health & Safety Limited is a private company limited by shares incorporated in England and Wales. The registered office is 4A Millennium City Office Park, Barnfield Way, Ribbleton, Preston, PR2 5DB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

The turnover shown in the profit and loss account represents amounts invoiced during the year for consultancy services, exclusive of Valued Added Tax.

 

Services provided during the year but not invoiced by the year end are included within accrued income.

 

Services invoiced during the year but not provided by the year end are included within deferred income.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:

Plant and machinery
1-5 years straight line
Fixtures, fittings & equipment
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

SURESITE HEALTH & SAFETY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 4 -

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss.

1.6
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

SURESITE HEALTH & SAFETY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The group operates a group payroll through the parent company. The company's share of salary costs is recharged by the parent company via a management charge.

2024
2023
Number
Number
Total
-
0
-
0
SURESITE HEALTH & SAFETY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 6 -
3
Tangible fixed assets
Plant and machinery
Fixtures, fittings & equipment
Total
£
£
£
Cost
At 1 April 2023
3,274
17,835
21,109
Additions
-
0
5,394
5,394
At 31 March 2024
3,274
23,229
26,503
Depreciation and impairment
At 1 April 2023
3,274
15,780
19,054
Depreciation charged in the year
-
0
3,367
3,367
At 31 March 2024
3,274
19,147
22,421
Carrying amount
At 31 March 2024
-
0
4,082
4,082
At 31 March 2023
-
0
2,055
2,055
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
194,536
162,589
Amounts owed by group undertakings
472,492
285,617
Other debtors
59,049
52,622
726,077
500,828
5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
21,093
16,661
Taxation and social security
91,942
41,225
Other creditors
77,078
75,260
190,113
133,146
SURESITE HEALTH & SAFETY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 7 -
6
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
7
Financial commitments, guarantees and contingent liabilities

The company is party to a multilateral guarantee with fellow group companies. At the year end the group's bank borrowings were £nil.

8
Related party transactions

The company has taken advantage of the exemption permitted under Section 1A paragraph 35C from disclosing transactions with its parent company and other wholly owned group companies.

2024-03-312023-04-01false05 November 2024CCH SoftwareCCH Accounts Production 2024.200No description of principal activityMr J G OldhamMr N Healyfalsefalse029138642023-04-012024-03-31029138642024-03-31029138642023-03-3102913864core:PlantMachinery2024-03-3102913864core:FurnitureFittings2024-03-3102913864core:PlantMachinery2023-03-3102913864core:FurnitureFittings2023-03-3102913864core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3102913864core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3102913864core:CurrentFinancialInstruments2024-03-3102913864core:CurrentFinancialInstruments2023-03-3102913864core:ShareCapital2024-03-3102913864core:ShareCapital2023-03-3102913864core:RetainedEarningsAccumulatedLosses2024-03-3102913864core:RetainedEarningsAccumulatedLosses2023-03-3102913864bus:Director12023-04-012024-03-3102913864bus:Director22023-04-012024-03-3102913864core:PlantMachinery2023-04-012024-03-3102913864core:FurnitureFittings2023-04-012024-03-31029138642022-04-012023-03-3102913864core:PlantMachinery2023-03-3102913864core:FurnitureFittings2023-03-31029138642023-03-3102913864core:WithinOneYear2024-03-3102913864core:WithinOneYear2023-03-3102913864bus:PrivateLimitedCompanyLtd2023-04-012024-03-3102913864bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3102913864bus:FRS1022023-04-012024-03-3102913864bus:AuditExemptWithAccountantsReport2023-04-012024-03-3102913864bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP